CHEK2 and ovarian serous adenocarcinoma: Similarly, the DDR checkpoint protein Chk2 is known to promote senescence through a p53-independent activation of p21 transcription in breast carcinoma, high grade serous ovarian cancer or immortalized keratinocyte cells [31,82].